Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 27, 2022
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
Cancer Medicine
|
January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial
So Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 11, 2019
Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression
Sook-Kyoung Heo, Eui-Kyu Noh, Yoo Kyung Jeong, et al.
Cancer Research and Treatment
|
May 4, 2023
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer
Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, et al.
Cancer Research and Treatment
|
April 20, 2019
Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
BMC Cancer
|
December 5, 2020
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Sook-Kyoung Heo, Eui-Kyu Noh, Ho-Min Yu, et al.
Journal for Immunotherapy of Cancer
|
June 19, 2021
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
Seung Joon Lee, Hannah Yang, Woo Ram Kim, et al.
Therapeutic Advances in Medical Oncology
|
July 21, 2022
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
Han Sang Kim, Chang Gon Kim, Jung Yong Hong, et al.
Liver Cancer
|
February 12, 2024
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma
Young Shin Song, Hannah Yang, Beodeul Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2021
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
Jaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 27, 2022
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
Cancer Medicine
|
January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial
So Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 11, 2019
Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression
Sook-Kyoung Heo, Eui-Kyu Noh, Yoo Kyung Jeong, et al.
Cancer Research and Treatment
|
May 4, 2023
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer
Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, et al.
Cancer Research and Treatment
|
April 20, 2019
Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
BMC Cancer
|
December 5, 2020
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Sook-Kyoung Heo, Eui-Kyu Noh, Ho-Min Yu, et al.
Journal for Immunotherapy of Cancer
|
June 19, 2021
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
Seung Joon Lee, Hannah Yang, Woo Ram Kim, et al.
Therapeutic Advances in Medical Oncology
|
July 21, 2022
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
Han Sang Kim, Chang Gon Kim, Jung Yong Hong, et al.
Liver Cancer
|
February 12, 2024
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma
Young Shin Song, Hannah Yang, Beodeul Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2021
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
Jaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 10